drugset / Trial / NCT01122381

Comparison of a Drug and Placebo in the Prevention of Migraine Headaches

NCT01122381 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.

Timeline

Start
2011-12
Primary completion
2014-04
Completion
2014-04

Outcome

Outcome not reported

Stopped (Enrollment): “poor recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ethosuximide Small molecule 250 mg —

Indications